Veeraraghavan S, Sharma O P
Division of Pulmonary and Critical Care Medicine, University of Southern California School of Medicine, Los Angeles 90033, USA.
Curr Opin Pulm Med. 1998 Jan;4(1):31-5. doi: 10.1097/00063198-199801000-00006.
Corticosteroids are effective in reducing the airway inflammation and controlling the symptoms of asthma. Many patients with chronic, severe asthma are steroid-dependent, requiring daily oral corticosteroids. Although corticosteroids may be effective, many patients suffer from their intolerable side effects. Various medications have been used as steroid-sparing agents in patients who suffer from the side effects of long-term high-dose steroids. While drugs like methotrexate and cyclosporine are promising, none have clearly been shown to be beneficial in most patients with asthma. The long-acting parenteral steroid triamcinolone acetonide has been tested by various investigators in these patients for over 20 years. Intramuscular triamcinolone appears to beneficial, with no significant increase in adverse effects.
皮质类固醇在减轻气道炎症和控制哮喘症状方面有效。许多慢性重度哮喘患者依赖类固醇,需要每日口服皮质类固醇。尽管皮质类固醇可能有效,但许多患者遭受其难以忍受的副作用。在长期高剂量类固醇副作用患者中,各种药物已被用作类固醇节省剂。虽然像甲氨蝶呤和环孢素这样的药物很有前景,但在大多数哮喘患者中,尚无明确证据表明它们有益。长效胃肠外类固醇曲安奈德已被众多研究者在这些患者中测试了20多年。肌内注射曲安奈德似乎有益,且不良反应无显著增加。